Company focused on editing the human leukocyte antigen (HLA) to transform autoimmunity Lead program, RG0401, in development for treatment-resistant or refractory rheumatoid arthritis (RA), as a one-time, curative treatment AURORA, CO, January 9, 2025 – RheumaGen, Inc., a cell and … Read More
News & Blog
The funds will support two Phase 2a clinical trials for the drug candidate CIL001, targeting cochlear synaptopathy (a leading cause of difficulty understanding speech in noise, tinnitus, and hyperacusis), as well as the advancement of preclinical development for the candidate … Read More
Established in Milan, Italy in 2021, Napo Therapeutics is focused on expanding access to crofelemer, Jaguar’s novel oral plant-based prescription drug, in Europe for orphan and/or rare diseases SAN FRANCISCO, CA / ACCESSWIRE / November 19, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) (Jaguar) today announced that Jaguar family company Napo Therapeutics … Read More
Case Studies
Discover the insights from the consensus document on Latin America Acne Management, published by experts from SPRIM PRO. This pivotal research highlights how generational shifts are reshaping acne treatment needs, enabling healthcare professionals in Latin America to enhance care for patients. … Read More
A top US-based, multi-national oral care brand seeking to revamp its educational materials to better accommodate the evolving needs of a dental student population now primarily dominated by millennials. … Read More
A leading provider of high-quality, direct-to-consumer (DTC) dietary supplements sought out opportunities to build thought leadership in a rapidly growing market category. As competition increased via the introduction of mediocre players and formulas, a differentiation strategy that focused attention on the importance of quality was critical. … Read More
